SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001714899-24-000086
Filing Date
2024-02-28
Accepted
2024-02-27 20:16:14
Documents
110
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K dnli-20231231.htm   iXBRL 10-K 2253208
2 EX-4.4 exhibit44q42023description.htm EX-4.4 29776
3 EX-10.34 exhibit1034compensationrec.htm EX-10.34 38374
4 EX-10.35 exhibit1035denaliinsiderpo.htm EX-10.35 128998
5 EX-21.1 exhibit211q42023subsidiari.htm EX-21.1 2940
6 EX-23.1 exhibit231q42023.htm EX-23.1 5589
7 EX-31.1 exhibit311q42023.htm EX-31.1 9894
8 EX-31.2 exhibit312q42023.htm EX-31.2 9914
9 EX-32.1 exhibit321q42023.htm EX-32.1 5554
10 EX-32.2 exhibit322q42023.htm EX-32.2 5684
16 dnli-20231231_g1.jpg GRAPHIC 177708
17 dnli-20231231_g10.jpg GRAPHIC 60158
18 dnli-20231231_g11.jpg GRAPHIC 994215
19 dnli-20231231_g12.jpg GRAPHIC 249454
20 dnli-20231231_g13.jpg GRAPHIC 500699
21 dnli-20231231_g14.jpg GRAPHIC 2168365
22 dnli-20231231_g15.jpg GRAPHIC 679129
23 dnli-20231231_g16.jpg GRAPHIC 1027525
24 dnli-20231231_g17.jpg GRAPHIC 387220
25 dnli-20231231_g2.jpg GRAPHIC 99884
26 dnli-20231231_g3.jpg GRAPHIC 208583
27 dnli-20231231_g4.jpg GRAPHIC 466480
28 dnli-20231231_g5.jpg GRAPHIC 485968
29 dnli-20231231_g6.jpg GRAPHIC 950321
30 dnli-20231231_g7.jpg GRAPHIC 703370
31 dnli-20231231_g8.jpg GRAPHIC 451670
32 dnli-20231231_g9.jpg GRAPHIC 344993
  Complete submission text file 0001714899-24-000086.txt   34593674

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dnli-20231231.xsd EX-101.SCH 70394
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dnli-20231231_cal.xml EX-101.CAL 73375
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dnli-20231231_def.xml EX-101.DEF 309052
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dnli-20231231_lab.xml EX-101.LAB 866602
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dnli-20231231_pre.xml EX-101.PRE 570711
112 EXTRACTED XBRL INSTANCE DOCUMENT dnli-20231231_htm.xml XML 1180715
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38311 | Film No.: 24689630
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)